Current concepts of PLP and its role in the nervous system

Microscopy Research and Technique

Volumn 41, Issue 5, 1998, Pages 344-358

  Griffiths, Ian ^a   Klugmann, Matthias ^b   Anderson, Thomas ^c   Thomson, Christine ^a   Vouyiouklis, Demetrius ^a   Nave, Klaus Armin ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c NONE

Author keywords

Axon glial interaction; Myelin; Myelin mutant; Oligodendrocyte; Pelizaeus Merzbacher disease

Indexed keywords

GENES; MAMMALS; NEURODEGENERATIVE DISEASES;

'CURRENT; ANIMAL SPECIES; AXON/GLIAL INTERACTION; ISOFORMS; MYELIN; MYELIN MUTANT; OLIGODENDROCYTES; PELIZAEU-MERZBACH DISEASE; PROTEOLIPIDS; TRANSGENIC MICE;

PROTEINS;

MUTANT PROTEIN; MYELIN; PROTEOLIPID PROTEIN;

ARTICLE; DEMYELINATION; GENE DOSAGE; GENE MUTATION; HUMAN; NERVE FIBER; NERVE FIBER DEGENERATION; NERVOUS SYSTEM; NONHUMAN; OLIGODENDROGLIA; PELIZAEUS MERZBACHER DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN STRUCTURE; SPASTIC PARESIS; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0032103916     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0029(19980601)41:5<344::AID-JEMT2>3.0.CO;2-Q     Document Type: Article

References (91)

1. Agrawal, H.C., and Agrawal, D. (1991) Proteolipid protein and DM-20 are synthesized by Schwann cells, present in myelin membrane, but they are not fatty acylated. Neurochem. Res., 16: 855-858.
2. Altschul, S.F., Madden, T.L., and Schafler, A.A. (1997) Gapped Blast and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res., 25: 3389-3402.
3. Anderson, T. J. (1997) Effects of increased dosage of the Plp gene:A study in transgenic mice. Thesis, University of Glasgow. Viewable at http://www.gla.ac.uk/Acad/FacVet/research/neurobiology/text2.htm
4. Anderson, T.J., Montague, P., Nadon, N.L., Nave, K.-A.., and Griffiths, I.R. (1997) Modification of Schwann cell phenotype with Plp transgenes: Evidence that the PLP and DM20 isoproteins are targeted to different cellular domains. J. Neurosci. Res., 50:13-22.
5. Anderson, T.J., Schneider, A., Barrie, J.A., Klugmann, M., McCulloch M.C., Kirkham, D., Kyriakides, E., Nave, K.-A.,. and Griffiths, I.R. (1998) Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene J. Comp. Neurol., 394:506-519.
6. Awatramani, R., Scherer, S., Grinspan, J., Collarini, E., Skoff, R., O'Hagan, D., Garbern, J., and Kamholz, J. (1997) Evidence that the homeodomain protein Gtx is involved in the regulation of oligodendrocyte myelination. J .Neurosci., 17: 6657-6668.
7. Bartlett, W.P., and Skoff, R.P. (1986) Expression of the jimpy gene in the spinal cords of heterozygous female mice. I. An early myelin deficit followed by compensation. J.Neurosci., 6: 2802-2812.
8. Bartlett, W.P., and Skoff, R.P. (1989) Expression of the jimpy gene in the spinal cords of heterozygous female mice. 2. Oligodendroglial and endothelial hyperplasia. Dev. Brain Res., 47:1-11.
9. Boison, D., and Stoffel, W. (1994) Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc. Natl. Acad. Sci. U.S.A., 91:11709-11713.
10. Bonneau, D., Rozet, J.-M., Bulteau, C., Berthier, M., Mettey, R., Gil, R., Munnich, A., and Le Merrer, M. (1993) X-linked spastic paraplegia (SPG2): Clinical heterogeneity at a single locus. J. Med. Genet., 30:381-384.
11. Cambi, F., Tang, X.M., Cordray, P., Fain, P.R., Keppen, L.D., and Barker, D.F. (1996) Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure hereditary spastic paraplegia. Neurology, 46:1112-1117.
12. Campagnoni, C.W., Garbay, B., Micevych, P., Pribyl, T., Kampf, K., Handley, V.W., and Campagnoni, A.T. (1992) DM20 mRNA splice product of the myelin proteolipid protein gene is expressed in the murine heart. J. Neurosci. Res., 33:148-155.
13. Diaz, R.S., Monreal, J., and Lucas, M. (1990) Calcium movements mediated by proteolipid protein and nucleotides in liposomes prepared with the endogenous lipids from white matter. J. Neurochem., 55:1304-1309.
14. Dickinson, P.J., Fanarraga, M.L., Griffiths, I.R., Barrie, J.A., Kyriakides, E., and Montague, P. (1996) Oligodendrocyte progenitors in the embryonic spinal cord express DM-20. Neuropathol. Appl. Neurobiol., 22:188-198.
15. Dickinson, P.J., Griffiths, I.R., Barrie, J.A., Kyriakides, E., Pollock, G.S., Barnett, S.C., Barrie, J.M., and Pollock, G.F. (1997) Expression of the dm-20 isoform of the pip gene in olfactory nerve ensheathing cells: Evidence from developmental studies. J. Neurocytol., 26:181-189.
16. Duncan, I.D., Hammang, J.P., and Jackson, K.F. (1987a) Myelin mosaicism in female heterozygotes of canine shaking pup and myelin-deficient rat mutants. Brain Res., 402:168-172.
17. Duncan, I.D., Hammang, J.P., and Trapp, B.D. (1987b) Abnormal compact myelin in the myelin-deficient rat: Absence of proteolipid protein correlates with a defect in the intraperiod line. Proc. Natl. Acad. Sci. U.S.A., 84:6287-6291.
18. Duncan, I.D., Jackson, K.F., Hammang, J.P., Marren, D., and Hoffman, R. (1993) Development of myelin mosaicism in the optic nerve of heterozygotes of the X-linked myelin-deficient (md) rat mutant. Dev. Biol., 157:334-347.
19. Duncan, I.D., Nadon, N.L., Hoffman, R.L., Lunn, K.F., Csiza, C., and Wells, M.R. (1995) Oligodendrocyte survival and function in the long-lived strain of the myelin deficient rat. J. Neurocytol., 24:745-762.
20. Fanarraga, M.L., Dickinson, P.J., Sommer, I., Montague, P., Kyriakides, E., and Griffiths, I.R. (1996) Evidence that some Oligodendrocyte progenitors in the developing optic pathways express the plp gene. Glia, 18:282-292.
21. Filbin, M.T. (1995) Myelin-associated glycoprotein: A role in myelination and in the inhibition of axonal regeneration. Curr. Opin. Neurobiol., 5:588-595.
22. Filbin, M.T. (1996) The muddle with MAG. Mol. Cell. Neurosci., 8:84-92.
23. Garbern, J.Y., Cambi, F., Tang, X.M., Sima, A.A.F., Vallat, J.M., Bosch, E.P., Lewis, R., Shy, M., Sohi, J., Kraft, G., Chen, K.L., Joshi, I., Leonard, D.G.B., Johnson, W., Raskind, W., Dlouhy, S.R., Pratt, V., Kodes, M.E., Bird, T., and Kamholz, J. (1997) Proteolipid protein is necessary in peripheral as well as central myelin. Neuron, 19:205-218.
24. 0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell, 71:565-576.
25. Gow, A., and Lazzarini, R.A. (1996) A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nature Genet., 13:422-428.
26. Gow, A., Friedrich, V.L., Jr., and Lazzarini, R.A. (1994a) Intracellular transport and sorting of the oligodendrocyte transmembrane proteolipid protein. J. Neurosci. Res., 37:563-573.
27. Gow, A., Friedrich, V.L., Jr., and Lazzarini, R.A. (1994b) Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J. Neurosci. Res., 37:574-583.
28. Griffiths, I.R. (1996) Myelin mutants: Model systems to study normal and abnormal myelination. BioEssays, 18:789-797.
29. Griffiths, I.R., Montague, P., and Dickinson, P. (1995a) The proteolipid protein gene. Neuropathol. Appl. Neurobiol., 21:85-96.
30. Griffiths, I.R., Sehneider, A., Anderson, J., and Nave, K.-A. (1995b) Transgenic and natural mouse models of proteolipid protein (PLP) related dysmyclination and demyelination. Brain Pathol., 5:275-281.
31. Griffiths, I.R., Dickinson, P., and Montague, P. (1995c) Expression of the proteolipid protein gene in glial cells of the post-natal peripheral nervous system of rodents. Neuropathol. Appl. Neurobiol., 21:97-110.
32. Griffiths, I.R., Klugmann, M., Anderson, T.J., Schwab, M.H., Jung, M., Zimmermann, F., and Nave, K.-A. (1997) Mouse models of dysmyelinating diseases: Axonal degeneration and glial cell death. J. Neurochem., 69:S257(Abstract).
33. Helynck, G., Luu, B., Nussbaum, J.L., Picken, D., Skalidis, G., Trifilieff, E., Van Dorsselaer, A., Seta, P., Sandeaux, R., Gavach, D., Heitz, F., Simon, D., and Spach, G. (1983) Brain proteolipids, isolation, purification and effects on ionic permeability of membranes. Eur. J. Biochem., 133:689-695.
34. Hodes, M.E., and Dlouhy, S.R. (1996) The proteolipid protein gene: double, double, ... and trouble. Am. J. Hum. Genet., 59:12-15.
35. Hodes, M.E., Pratt, V.M., and Dlouhy, S.R. (1993) Genetics of Pelizaeus-Merzbacher disease. Dev. Neurosci., 15:383-394.
36. Hodes, M.E., Blank, C.A., Pratt, V.M., Morales, J., Napier, J., and Dlouhy, S.R. (1997) Nonsense mutation in exon 3 of the proteolipid protein gene (PLP) in a family with an unusual form of Pelizaeus-Merzbacher disease. Am. J. Med. Genet., 69:121-125.
37. Hudson, L.D., Ko, N., and Kim, J.G. (1996) Control of myelin gene expression. In: Glial Cell Development: Basic Principles and Clinical Relevance. K.R. Jessen and W.D. Richardson, eds. Bios Scientific Publishers, Oxford, pp. 101-121.
38. Hudson, L.D., Kim, J.G., Wiese, C., Yao, D.-L., Liu, X., Webster, H.d., Agoston, Dv., and Armstrong, R. (1997) Transcriptional controls in the oligodendrocyte lineage. In: Molecular Signalling and Regulation in Glial Cells. A Key to Remyelination and Functional Repair. G. Jeserich, H.H. Althaus, C. Richter-Landsberg, and R. Heumann, eds. Springer-Verlag, Berlin, pp. 182-190.
39. Inoue, Y., Kagawa, T., Matsumura, Y, Ikenaka, K., and Mikoshiba, K. (1996) Cell death of oligodendrocytes or demyelination induced by overexpression of proteolipid protein depending on expressed gene dosage. Neurosci. Res., 25:161-172.
40. Johnson, R.S., Roder, J.C., and Riordan, J.R. (1995) Over-expression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice. J. Neurochem., 64:967-976.
41. Jung, M., Sommer, I., Schachner, M., and Nave, K.-A. (1996) Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): Evidence that PLP misfolding underlies dysmyelination in mutant mice. J. Neurosci., 16:7920-7929.
42. Kagawa, T., Ikenaka, K., Inoue, Y., Kuriyama, S., Tsujii, T., Nakao, J., Nakajima, K., Aruga, J., Okano, H., and Mikoshiba, K. (1994) Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron, 13:427-442.
43. Kalwy, S.A., Smith, R., and Kidd, G.J. (1997) Myelin proteolipid protein expressed in COS-1 cells is targeted to actin-associated surfaces. J. Neurosci. Res., 48:201-211.
44. Kitagawa, K., Sinoway, M.P., Yang, C., Gould, R.M., and Colman, D.R. (1993) A proteolipid protein gene family: Expression in sharks and rays and possible evolution from an ancestral gene encoding a pore-forming polypeptide. Neuron, 11:433-448.
45. Klugmann, M., Schwab, M.H., Pühlhofer, A., Schneider, A., Zimmermann, F., Griffiths, I.R., and Nave, K.-A. (1997) Assembly of CNS myelin in the absence of proteolipid protein. Neuron, 18:59-70.
46. Knapp, P.E. (1996) Proteolipid protein: Is it more than just a structural component of myelin. Dev. Neurosci., 18:297-308.
47. Knapp, P.E., Skoff, R.P., and Redstone, D.W. (1986) Oligodendroglial cell death in jimpy mice: An explanation for the myelin deficit. J. Neurosci., 6:2813-2822.
48. Kobayashi, H., Hoffman, E.P., and Marks, H.G. (1994) The rumpshaker mutation in spastic paraplegia. Nature Genet., 7:351-352.
49. Kobayashi, H., Garcia, C.A., Alfonso, G., Marks, H.G., and Hoffman, E.P. (1996) Molecular genetics of familial spastic paraplegia: A multitude of responsible genes. J. Neurol. Sci., 137:131-138.
50. Matsuda, Y., Koito, H., and Yamamoto, H. (1997) Induction of myelin-associated glycoprotein expression through neuron-oligodendrocyte contact. Dev. Brain Res., 100:110-116.
51. McPhilemy, K., Mitchell, L.S., Griffiths, I.R., Morrison, S., Deary, A.W., Sommer, I., and Kennedy, P.G.E. (1990) Effect of optic nerve transection upon myelin protein gene expression by oligodendrocytes: Evidence for axonal influences on gene expression. J. Neurocytol., 19:494-503.
52. Mitchell, L.S., Gillespie, C.S., McAllister, F., Fanarraga, M.L., Kirkham, D., Kelly, B., Brophy, P.J., Griffiths, I.R., Montague, P., and Kennedy, P.G.E. (1992) Developmental expression of the major myelin protein genes in the CNS of the X-linked hypomyelinating mutant rumpshaker. J. Neurosci. Res., 33:205-217.
53. Montague, P., and Griffiths, I.R. (1997) Molecular biology of the glia: Components of myelin-PLP and minor myelin proteins. In: Molecular Biology of Multiple Sclerosis. W.C. Russell, ed. J.Wiley & Sons, Chichester, pp. 55-69.
54. Nadon, N.L., Duncan, I.D., and Hudson, L.D. (1990) A point mutation in the proteolipid protein gene of the "shaking pup" interupts oligodendrocyte development. Development, 110:529-537.
55. Nadon, N.L., Arnheiter, H., and Hudson, L.D. (1994) A combination of PLP and DM20 transgenes promotes partial myelination in the jimpy mouse. J. Neurochem., 63:822-833.
56. Nadon, N.L., Miller, S., Draeger, K., and Salvaggio, M. (1997) Myelin proteolipid DM20: Evidence for function independent of myelination. Int. J. Dev. Neurosci., 15:285-293.
57. Nance, M.A., Boyadjiev, S., Pratt, V.M., Taylor, S., Hodes, M.E., and Dlouhy, S.R. (1996) Adult-onset neurodegenerative disorder due to proteolipid protein gene mutation in the mother of a man with Pelizaeus-Merzbacher disease. Neurology, 47:1333-1335.
58. Nave, K.-A.. (1996) Myelin-specific genes and their mutations in the mouse. In: Glial Cell Development. Basic Principles and Clinical Relevance. K.R. Jessen and W.D. Richardson, eds. Bios, Oxford, pp. 141-164.
59. Nave, K.-A.., and Boespflug-Tanguy, O. (1996) X-linked developmental defects in myelination: From mouse mutants to human genetic diseases. Neuroscientist, 2:33-43.
60. Nave, K.-A., Lai, C., Bloom, F.E., and Milner, R.J. (1987) Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc. Natl. Acad. Sci. U.S.A., 84:5665-5669.
61. Pahl, H.L., and Baeuerle, P.A. (1997) The ER-overload response: Activation of NF-kappaB. TIBS, 22:63-67.
62. Pribyl, T.M., Campagnoni, C.W., Kampf, K., Kashima, T., Handley, V.W., McMahon, J., and Campagnoni, A.T. (1996) Expression of the myelin proteolipid protein gene in the human fetal thymus. J. Neuroimmunol., 67:125-130.
63. Puckett, C., Hudson, L.D., Ono, K., Benecke, J., Dubois-Dalcq, M., and Lazzarini, R.A. (1987) Myelin-specific proteolipid protein is expressed in myelinating Schwann cells but is not incorporated into myelin sheaths. J. Neurosci. Res., 18:511-518.
64. Readhead, C., Popko, B., Takahashi, N., Shine, H.D., Saavedra, R.A., Sidman, R.L., and Hood, L. (1987) Expression of a myelin basic protein gene in transgenic shiverer mice: Correction of the dysmyelinating phenotype. Cell, 48:703-712.
65. Readhead, C., Schneider, A., Griffiths, I.R., and Nave, K.-A. (1994) Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron, 12:583-595.
66. Richardson, W.D., Pringle, N.P., Yu, W.P., and Hall, A.C. (1997) Origins of spinal cord oligodendrocytes: Possible developmental and evolutionary relationships with motor neurons. Dev. Neurosci., 19:58-68.
67. Rosenbluth, J., Stoffel, W., and Schiff, R. (1996) Myelin structure in proteolipid protein (PLP)-null mouse spinal cord. J. Comp. Neurol., 371:336-344.
68. Saugier-Veber, P., Munnich, A., Bonneau, D., Rozet, J.-M., Le Merrer, M., Gil, R., and Boespflug-Tanguy, O. (1994) X-linked spastic-paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nature Genet., 6:257-262.
69. Schneider, A., Montague, P., Griffiths, I.R., Fanarraga, M.L., Kennedy, P.G.E., Brophy, P.J., and Nave, K.-A. (1992) Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature, 358:758-761.
70. Schneider, A., Griffiths, I.R., Readhead, C., and Nave, K.-A. (1995) Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein Proc. Natl. Acad. Sci. U.S.A., 92:4447-4451.
71. Seitelberger, F. (1995) Neuropathology and genetics of Pelizaeus-Merzbacher disease. Brain Pathol., 5:267-273.
72. Seitelberger, F., Urbanits, S., and Nave, K.-A. (1996) Pelizaeus-Merzbacher disease. In: Neurodystrophies and Neurolipidnses. H.W. Moser, ed. Elsevier Science, Amsterdam, pp. 559-579.
73. Sinoway, M.P., Kitagawa, K., Timsit, S., Hashim, G.A., and Colmon, D.R. (1994) Proteolipid protein interactions in transfectants: Implications for myelin assembly. J. Neurosci. Res., 37:551-562.
74. Skoff, R.P., and Ghandour, M.S. (1995) Oligodendrocytes in female carriers of the jimpy gene make more myelin than normal oligodendrocytes. J. Comp. Neurol., 355:24-133.
75. Snipes, G.J., and Suter, U. (1995a) Molecular anatomy and genetics of myelin proteins in the peripheral nervous system. J. Anat., 186:483-494.
76. Snipes, G.J., and Suter, U. (1995b) Molecular basis of common hereditary motor and sensory neuropathies in humans and in mouse models. Brain Pathol., 5:233-247.
77. Stoffel, W., Boison, D., and Bussow, H. (1997) Functional analysis in vivo of the double mutant mouse deficient in both proteolipid protein (PLP) and myelin basic protein (MBP) in the central nervous system. Cell Tissue Res., 289:195-206.
78. Thomson, C.E., Montague, P., Jung, M., Nave, K.-A., Griffiths, I.R., and Nave, K.A. (1997) Phenotypic severity of murine Plp mutants reflects in vivo and in vitro variations in transport of PLP isoproteins. Glia, 20:322-332.
79. Timsit, S.G., Bally-Cuif, L., Colman, D.R., and Zalc, B. (1992) DM-20 mRNA is expressed during the embryonic development of the nervous system of the mouse. J. Neurochem., 58:1172-1175.
80. Timsit, S., Martinez, S., Allinquant, B., Peyron, F., Puelles, L., and Zalc, B. (1995) Oligodendrocytes originate in a restricted zone of the embryonic ventral neural tube defined by DM-20 mRNA expression. J. Neurosci., 15:1012-1024
81. Tosic, M., Dolivo, M., Amiguet, P., Domanska-Janik, K., and Matthieu, J.-M. (1993) Paralytic tremor (pt) rabbit: A sex-linked mutation affecting proteolipid protein-gene expression. Brain Res., 625:307-312.
82. Trapp, B.D., Nishiyama, A., Cheng, D., and Macklin, E. (1997) Differentiation and death of premyclinating oligodendrocytes in developing rodent brain. J. Cell Biol., 137:459-468.
83. Weimbs, T., and Stoffel, W. (1992) Proteolipid protein (PLP) of CNS myelin: Positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. Biochemistry, 31:12289-12296.
84. Wight, P.A., and Dobretsova, A. (1997) The first intron of the myelin proteolipid protein gene confers cell type-specific expression by a transcriptional repression mechanism in non-expressing cell types. Gene, 201:111-117.
85. Wight, P.A., Dobretsova, A., and Macklin, W.B. (1997) Regulation of murine myelin proteolipid protein gene expression. J. Neurosci. Res., 50:917-927.
86. Williams, W.C., II, and Gard, A.L. (1997) In vitro death of jimpy oligodendrocytes: Correlation with onset of DM-20/PLP expression and resistance to oligodendrogliotrophic factors. J. Neurosci. Res., 50:177-189.
87. Yan, Y., Lagenaur, C., and Narayanan, V. (1993) Molecular cloning of M6: Identification of a PLP/DM20 gene family Neuron, 11:423-431.
88. Yan, Y.M., Narayanan, V., and Lagenaur, C. (1996) Expression of members of the proteolipid protein gene family in the developing murine central nervous system. J. Comp. Neurol., 370:465-478.
89. Yang, X.Y., and Skoff, R.P. (1997) Proteolipid protein regulates the survival and differentiation of oligodendrocytes. J. Neurosci., 17: 2056-2070.
90. Yoshida, M., and Colman, D.R. (1996) Parallel evolution and coexpression of the proteolipid proteins and protein zero in vertebrate myelin. Neuron, 16:1115-1126.
91. Yu, W.-P., Collarini, E.J., Pringle, N.P., and Richardson, W.D. (1994) Embryonic expression of myelin genes: Evidence for a focal source of oligodendrocyte precursors in the ventricular zone of the neural tube. Neuron, 12:1353-1362.